Test Code SFEC Iron and Total Iron-Binding Capacity, Serum
Ordering Guidance
The recommended primary test for assessment of iron deficiency is serum ferritin. Order FERR1 / Ferritin, Serum.
Additional Testing Requirements
Although measurement of serum iron, total iron-binding capacity, and percent saturation should not be used as primary testing for iron deficiency, they may be helpful when used in conjunction with ferritin and soluble transferrin receptor, especially in patients with inflammation. Order both FERR1 / Ferritin, Serum; and STFR / Soluble Transferrin Receptor (sTfR), Serum with this test.
Specimen Required
Patient Preparation:
1. Fasting (12 hours)
2. For 24 hours before collection, patient should not take iron-containing supplements.
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Draw blood before noon (preferred).
2. Within 2 hours of collection, serum gel tubes should be centrifuged.
3. Within 2 hours of collection, red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial.
Useful For
Screening for chronic iron overload diseases, particularly hereditary hemochromatosis
Screening for iron deficiency as the cause of anemia
Monitoring treatment for iron deficiency anemia
This test should not be used as the primary test for iron deficiency.
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
IRON | Iron | No | Yes |
TIBC | Total Iron Binding Capacity | No | Yes |
SAT | Percent Saturation | No | Yes |
Testing Algorithm
For more information see Hereditary Hemochromatosis Algorithm.
Special Instructions
Method Name
IRON: Colorimetric Assay
TIBC: Turbidity/Calculation
SAT: Calculation
Reporting Name
Iron and Total Fe Binding Cap, SSpecimen Type
SerumSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 180 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Clinical Information
Transferrin is the plasma iron transport protein that binds iron strongly to keep iron nonreactive in circulation and deliver it to cells with transferrin receptors. The rate of transferrin synthesis in the liver can be altered according to the body’s iron requirements and iron reserves. The circulating concentration increases in response to iron deficiency and decreases in response to iron overload. Transferrin is generally only 25% to 30% saturated with iron. Total iron-binding capacity (TIBC) is estimated from the transferrin concentration using the molecular weight of transferrin, accounting for each transferrin molecule that can bind 2 atoms of iron.
Iron deficiency, iron overload, and anemia of chronic disease are the most prevalent disorders of iron metabolism. Serum iron, TIBC, and percent saturation are widely used for the diagnosis of iron deficiency and iron overload disorders, such as hemochromatosis. Iron concentration and percent saturation decrease with iron deficiency and increase when iron is in excess. However, serum ferritin is a much more sensitive and reliable test for demonstration of iron deficiency.
Anemia of chronic disease is often observed in patients with autoimmune diseases, chronic kidney diseases, inflammatory bowel disease, and chronic heart failure. It is diagnosed when serum iron concentrations are low despite normal serum ferritin concentrations indicating adequate iron stores. However, in the presence of inflammation, ferritin can mask iron deficiency; therefore, measuring soluble transferrin receptors is suggested.
The biologic variation of iron and, therefore, iron saturation is notable in normal healthy persons and in various clinical disorders owing to both diurnal variation and post-prandial effects. The intraindividual day-to-day variation of iron and iron saturation is approximately 25% to 30%.(1) Recommendations for blood sampling for iron and iron saturation measurements are contradictory, however; minimizing influence of these effects can be accomplished by collecting during the morning after an overnight fast.
Reference Values
IRON
Males: 50-150 mcg/dL
Females: 35-145 mcg/dL
TOTAL IRON-BINDING CAPACITY
250-400 mcg/dL
PERCENT SATURATION
14-50%
Interpretation
Serum iron concentration is elevated in iron overload conditions including hemochromatosis.(1)
Serum iron concentration is decreased in iron deficiency, iron deficiency anemia, and anemia of chronic disease.(1)
Total iron-binding capacity values are elevated in anemia of chronic disease and iron overload conditions.(1)
Total iron-binding capacity values are decreased in iron deficiency, iron deficiency anemia, and iron-refractory iron deficiency anemia.(1)
Percent saturation often exceeds 45% in hereditary hemochromatosis and 90% in advanced iron overload states.(2)
Percent saturation less than 16% is generally used to screen for iron deficiency, but a threshold of 20% is used in the presence of inflammation.(3)
For more information about hereditary hemochromatosis testing, see Hereditary Hemochromatosis Algorithm.
Cautions
Serum iron, total iron-binding capacity, and percent saturation are widely used for the diagnosis of iron deficiency. However, serum ferritin is a much more sensitive and reliable test for demonstration of iron deficiency.
Measurement of serum iron, total iron-binding capacity, and percent saturation should not be used as the primary test for iron deficiency. It may be helpful in conjunction with ferritin and soluble transferrin receptor, especially in patients with inflammation.
Clinical Reference
1. Swinkels DW. Iron metabolism. In: Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023:chap 40
2. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis [published correction appears in Am J Gastroenterol. 2019 Dec;114(12):1927. doi:10.14309/ajg.0000000000000469]. Am J Gastroenterol. 2019;114(8):1202-1218. doi:10.14309/ajg.0000000000000315
3. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-916. doi:10.1016/S0140-6736(15)60865-0
Method Description
Iron:
Under acidic conditions, iron is liberated from transferrin. Lipemic samples are clarified by the detergent. Ascorbate reduces the released Fe(3+) ions to Fe(2+) ions which then react with FerroZine to form a colored complex. The color intensity is directly proportional to the iron concentration and can be measured photometrically.(Package insert: IRON2. Roche Diagnostics; V9, 09/2019)
Transferrin:
Human transferrin forms a precipitate with a specific antiserum, which is determined turbidimetrically.(Package insert:TRSF2 reagent. Roche Diagnostics; v10.0, 04/2022)
Calculations:
Total iron-binding capacity (TIBC) = Transferrin x 1.18
Percent saturation = (Iron/TIBC) x 100
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysSpecimen Retention Time
7 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
83540-Iron
83550-Iron-binding capacity
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
SFEC | Iron and Total Fe Binding Cap, S | 50190-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
SAT | Percent Saturation | 2502-3 |
IRON | Iron | 2498-4 |
TIBC | Total Iron Binding Capacity | 2500-7 |